What Is the New Weight Loss Pill Everyone’s Talking About in 2025?

The newest breakthrough in weight loss medication is a once-daily pill form of GLP-1 therapy. The most promising candidate is Orforglipron, a non-injectable GLP-1 receptor agonist developed by Eli Lilly. This oral pill is generating excitement because it offers similar results to injectable drugs like Wegovy and Zepbound—but in pill form.

While still undergoing approval in some regions, Orforglipron is expected to become widely available in 2025.

1. What is Orforglipron and how does it work?

Orforglipron is a GLP-1 receptor agonist, similar to semaglutide (Wegovy) or tirzepatide (Zepbound). It mimics a gut hormone that:

Slows stomach emptying
Suppresses appetite
Improves blood sugar control
Promotes fat loss over time

Unlike its injectable counterparts, Orforglipron is taken as a daily pill, making it appealing to patients who dislike needles.

2. How effective is the new weight loss pill?

Early clinical trials of Orforglipron showed impressive results:

Participants lost up to 15% of their body weight after 36–48 weeks
Appetite and food cravings were significantly reduced
Side effects were similar to GLP-1 injections: nausea, bloating, and mild fatigue

These results make it comparable to Wegovy, offering a powerful, needle-free option for those struggling with obesity or related conditions.

3. Who qualifies for the new pill?

Orforglipron is expected to be approved for:

Adults with a BMI of 30 or higher, or
Adults with BMI 27+ and a weight-related condition like high blood pressure, Type 2 diabetes, or PCOS

As with all GLP-1 medications, it will likely require medical screening and monitoring. Your doctor may also look for:

A history of unsuccessful weight loss attempts
No disqualifying conditions like pancreatitis or thyroid tumors
A willingness to adopt lifestyle changes alongside medication

4. Will insurance cover the new weight loss pill?

Coverage will depend on:

FDA approval status
Your insurance plan’s drug formulary
Whether you meet medical necessity criteria
Prior authorization and documentation from your doctor

If Orforglipron follows the same path as Wegovy and Zepbound, it may be covered for patients who meet BMI and health risk requirements, particularly with commercial insurance.

5. What other weight loss pills are available?

Until Orforglipron becomes widely accessible, other options include:

Contrave – a combination of bupropion and naltrexone
Qsymia – phentermine with topiramate
Alli (orlistat) – available over-the-counter
Metformin – off-label use for insulin resistance and PCOS

However, these older pills generally lead to less weight loss than the newer GLP-1-based options.

Final thought

The future of weight loss medication is expanding beyond injections. Pills like Orforglipron offer a promising, needle-free solution for safe and sustained weight loss. As this new generation of medications becomes available, it’s important to talk to a healthcare provider to determine which option best fits your health goals, insurance coverage, and lifestyle.

If symptoms get worse or don’t improve, visit your local urgent care provider for professional evaluation.
Hey Did You Know We Have an IV Therapy Spa Inside? Check out our drip menu!